Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-Basket Study

Diamond Eli L.; Subbiah Vivek; Lockhart Craig; Blay Jean-Yves; Faris Jason E.; Puzanov Igor; Chau Ian; Raje Noopur S.; Wolf Juergen S.; Erinjeri Joe; Torrisi Jean; Ulaner Gary; Lacouture Mario; Robson Susan; Makrutzki Martina; Elez Elena; Tabernero Josep; Abdel-Wahab Omar; Baselga Jose; Hyman David M.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-Basket Study

【24h】

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-Basket Study

机译：Vemurafenib在具有BRAF（V600）突变的Erdheim-Chester病（ECD）和Langerhans细胞组织增生症（LCH）患者中：独立于组织学的VE-Basket研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共5页
作者
Diamond Eli L.; Subbiah Vivek; Lockhart Craig; Blay Jean-Yves; Faris Jason E.; Puzanov Igor; Chau Ian; Raje Noopur S.; Wolf Juergen S.; Erinjeri Joe; Torrisi Jean; Ulaner Gary; Lacouture Mario; Robson Susan; Makrutzki Martina; Elez Elena; Tabernero Josep; Abdel-Wahab Omar; Baselga Jose; Hyman David M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-Basket Study [J] . Diamond Eli L., Subbiah Vivek, Lockhart Craig, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：Vemurafenib在具有BRAF（V600）突变的Erdheim-Chester病（ECD）和Langerhans细胞组织增生症（LCH）患者中：独立于组织学的VE-Basket研究
2. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. [J] . Julien Haroche, Fleur Cohen-Aubart, Jean-Fran?ois Emile, Blood: The Journal of the American Society of Hematology . 2013,第9期

机译：维拉非尼在多系统性和难治性Erdheim-Chester病以及携带BRAF V600E突变的朗格汉斯细胞组织细胞增生症中具有显着疗效。
3. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. [J] . Julien Haroche, Fleur Cohen-Aubart, Jean-Fran?ois Emile, Blood: The Journal of the American Society of Hematology . 2013,第9期

机译：维拉非尼在多系统性和难治性Erdheim-Chester病以及携带BRAF V600E突变的朗格汉斯细胞组织细胞增生症中具有显着疗效。
4. Efficacy of Vemurafenib in Patients With Non–Small-Cell Lung Cancer With BRAF V600 Mutation: An Open-Label Single-Arm Cohort of the Histology-Independent VE-BASKET Study [O] . Vivek Subbiah, Radj Gervais, Gregory Riely, -1

机译：vemureafenib对具有BRAF v600突变的非小细胞肺癌患者的疗效：开放标签单臂队列的组织学 - 独立的VE篮子研究
5. Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation [O] . Charles Julie, Beani Jean-Claude, Fiandrino Giacomo, 2014

机译：携带BRAF V600E突变的严重皮肤朗格汉斯细胞组织细胞增生症患者对vemurafenib的主要反应

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-Basket Study

著录项

相似文献

相关主题

期刊订阅